ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

TIL and Anti-PD1 in Metastatic Melanoma

Leiden University · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
drugnivolumabtoxicity
toxicity, drug, adverse drug event, effects of immunotherapy, metastatic melanoma, anti-pd1, til, interferon-alpha, adoptive cell therapy, nivolumab, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1009054
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.